FIELD: medicine.
SUBSTANCE: osteoporosis is simulated by a bilateral ovariectomy and osteoporosis-related femoral factures in Wistar rats; the pathological conditions are corrected by a pharmacological correction with recombinant erythropoietin in a sub-erythrostimulating dose of 50 international units/kg administered once a week as a single subcutaneous injection for eight weeks, and for twelve weeks in case of the fractures associated with simulated osteoporosis.
EFFECT: invention enables preventing the negative changes in the bone tissue microcirculation accompanying osteoporosis and in a callus in the osteoporosis-related fractures.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CORRECTION OF BONE TISSUE MICROCIRCULATON IN EXPERIMENTAL OSTEOPOROSIS AND ASSOCIATED FRACTURES WITH COMBINATION OF RECOMBINANT ERYTHROPOIETIN AND ROSUVASTATIN | 2013 |
|
RU2541184C1 |
METHOD FOR ROSUVASTATIN CORRECTION OF BONE MICROCIRCULATION IN EXPERIMENTAL OSTEOPOROSIS AND ACCOMPANYING FRACTURES | 2013 |
|
RU2538612C1 |
METHOD FOR CORRECTING BONE MICROCIRCULATION ACCOMPANYING OSTEOPOROSIS AND UNDERLYING FRACTURES WITH USE OF COMBINATION OF L-ARGININE AND LOSARTAN | 2013 |
|
RU2542425C1 |
METHOD OF CORRECTING MICROCIRCULATION IN BONE TISSUE WITH L-NORVALIN IN CASE OF EXPERIMENTAL OSTEOPOROSIS AND FRACTURES AT ITS BACKGROUND | 2013 |
|
RU2540926C1 |
METHOD FOR CORRECTING BONE MICROCIRCULATION ACCOMPANYING EXPERIMENTALOSTEOPOROSIS AND UNDERLYING FRACTURES WITH USE OF COMBINATION OF L-ARGININE AND ENALAPRIL | 2013 |
|
RU2542424C1 |
METHOD OF CORRECTING MICROCIRCULATION IN BONE TISSUE WITH COMBINATION OF L-NORVALIN AND ROSUVASTATIN IN CASE OF EXPERIMENTAL OSTEOPOROSIS AND FRACTURES AT ITS BACKGROUND | 2013 |
|
RU2540927C1 |
METHOD FOR THE CORRECTION OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 3-HYDROXY-2-ETHYL-6-METHYLPYRIDINIUM NICOTINATE IN EXPERIMENT | 2021 |
|
RU2763011C1 |
METHOD FOR CORRECTING OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM HYDROXYBUTANEDIOATE IN EXPERIMENT | 2021 |
|
RU2775439C1 |
METHOD FOR RESERVATROL AND ENALAPRIL BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437160C1 |
METHOD FOR RESERVATROL-BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437161C1 |
Authors
Dates
2015-02-10—Published
2013-09-23—Filed